德塞佩卢马布治疗早期发作的严重过敏性喘,持续的气流限制和小呼吸道功能障碍:可治疗的特征方法
Francesco Menzella1, Claudio Sorino2, Carlo Lombardi3
1Pulmonology Unit, S. Valentino Hospital, Montebelluna (TV), AULSS2 Marca Trevigiana, Italy.
Drugs in context
|October 9, 2025
概括
采佩卢马布 (TZP) 治疗显著改善了一个年轻女子的严重过敏性喘,即使有持续的空气流量限制. 这种生物方法准了上游炎症,在其他治疗方法失败时逆转了小呼吸道功能障碍.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 过敏 过敏是一种过敏.
背景情况:
- 严重的过敏性喘带来了挑战,特别是与同时发生的持续空气流量限制和小呼吸道功能障碍.
- 传统的治疗方法,包括吸入的三重疗法,可能无法在所有患者中充分控制喘.
- 早期发作的过敏性喘中的非典型功能特征需要探索替代治疗策略.
研究的目的:
- 报告一个严重的过敏性喘病例与异常功能特征成功治疗tezepelumab.
- 突出特定功能缺陷的识别和治疗在指导生物治疗选择中的作用.
- 为了评估tezepelumab在对标准治疗无反应的患者的疗效.
主要方法:
- 一个18岁的女子患有早期发作的严重过敏性喘病例报告.
- 评估包括肺功能测试 (精神测量,FOT) 和喘控制测试.
- 在高剂量吸入三重疗法失败后,治疗涉及启动tezepelumab (胸膜 stromal lymphopoietin 抑制剂).
主要成果:
- 采佩卢马布治疗导致显著的临床改善,喘控制测试得分从12升至22.
- 肺功能明显改善:强迫呼气体积在1秒内从预测的67%增加到95%.
- 通过FOT参数和空气捕获指出的小呼吸道功能障碍,大大改善,剩余体积正常化.
结论:
- 基于可治疗特征的个性化生物治疗选择,如小呼吸道功能障碍,可以在严重的喘中有效.
- 采佩鲁马布在患有早期过敏性喘和非典型功能特征的患者中显示出有效性,这表明它在向上游炎症方面发挥了作用.
- 这一案例支持在严重喘中采用精准医学方法,强调为最佳治疗选择进行多维评估.
相关概念视频
01:19Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:30Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:26Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
01:30Asthma-IV: Nursing Management
3.7K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.7K